Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Organigram Hlds Inc (OGI)

Organigram Hlds Inc (OGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 191,751
  • Shares Outstanding, K 103,370
  • Annual Sales, $ 119,860 K
  • Annual Income, $ -184,340 K
  • 60-Month Beta 1.07
  • Price/Sales 1.62
  • Price/Cash Flow N/A
  • Price/Book 0.95
Trade OGI with:

Options Overview Details

View History
  • Implied Volatility 96.47% ( -2.19%)
  • Historical Volatility 92.06%
  • IV Percentile 48%
  • IV Rank 8.96%
  • IV High 766.76% on 06/02/23
  • IV Low 30.53% on 08/22/23
  • Put/Call Vol Ratio 0.01
  • Today's Volume 168
  • Volume Avg (30-Day) 828
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 21,945
  • Open Int (30-Day) 21,196

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.06
  • Number of Estimates 3
  • High Estimate -0.05
  • Low Estimate -0.07
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7800 +4.21%
on 04/17/24
2.3700 -21.73%
on 04/04/24
-0.4350 (-19.00%)
since 04/03/24
3-Month
1.6900 +9.76%
on 02/05/24
2.9100 -36.25%
on 03/26/24
+0.0250 (+1.37%)
since 02/02/24
52-Week
0.9702 +91.20%
on 10/27/23
2.9100 -36.25%
on 03/26/24
-0.1050 (-5.36%)
since 05/03/23

Most Recent Stories

More News
5 Microcap Stocks With 65% or More Upside Potential

While they do carry higher-than-average risk, these microcaps also offer major upside potential for investors seeking startup-sized returns.

BTBT : 2.20 (+2.33%)
^BTCUSD : 63,246.93 (+0.60%)
ERJ24 : 3,144.04s (-0.63%)
GOEV : 2.77 (-2.12%)
KRON : 1.0200 (-0.97%)
OGI : 1.8550 (-1.33%)
QBTS : 1.4000 (-3.45%)
Organigram (OGI) Q1 2024 Earnings Call Transcript

OGI earnings call for the period ending December 31, 2023.

OGI : 1.8550 (-1.33%)
Organigram (OGI) Q4 2023 Earnings Call Transcript

OGI earnings call for the period ending September 30, 2023.

OGI : 1.8550 (-1.33%)
Why Marijuana Stocks Triumphed on Monday

There's some potentially very good news coming soon from the halls of Congress.

CURLF : 5.6500 (+0.36%)
CRLBF : 2.1815 (+1.00%)
OGI : 1.8550 (-1.33%)
CRON : 2.68 (+0.75%)
3 Cannabis Stocks to Consider Buying as HHS Recommends Easing Restrictions on Marijuana

Cannabis stocks could deliver outsized gains if marijuana is rescheduled, per a recent HHS recommendation. While the DEA weighs its options, here's a look at three names with significant upside potential,...

OGI : 1.8550 (-1.33%)
CRON : 2.68 (+0.75%)
GRWG : 2.69 (+5.91%)
Organigram (OGI) Q3 2023 Earnings Call Transcript

OGI earnings call for the period ending June 30, 2023.

OGI : 1.8550 (-1.33%)
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates

OrganiGram (OGI) delivered earnings and revenue surprises of -100% and 9.74%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?

OGI : 1.8550 (-1.33%)
EOLS : 13.30 (+0.61%)
Organigram Reports Second Quarter Fiscal 2023 Results

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2023...

OGI : 1.8550 (-1.33%)
OGI.TO : 2.56 (-1.16%)
Why Tilray Stock Sank and Moved the Canadian Cannabis Market Today

Tilray is buying Hexo at a big discount to Monday's closing share price.

TLRY : 2.10 (+3.96%)
HEXO : 0.7100 (+2.45%)
OGI : 1.8550 (-1.33%)
Which Canadian Cannabis Company Will Be the Next Takeover Target?

Consolidation is going to be the key theme among Canadian cannabis companies in 2023 and beyond.

TLRY : 2.10 (+3.96%)
ACB : 6.74 (-3.30%)
OGI : 1.8550 (-1.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Organigram Holdings Inc. is a licensed producer of cannabis and cannabis-derived products primarily in Canada, through a wholly owned subsidiary. Organigram Holdings Inc. is based in Moncton, Canada.

See More

Key Turning Points

3rd Resistance Point 2.0167
2nd Resistance Point 1.9783
1st Resistance Point 1.9167
Last Price 1.8550
1st Support Level 1.8167
2nd Support Level 1.7783
3rd Support Level 1.7167

See More

52-Week High 2.9100
Fibonacci 61.8% 2.1690
Fibonacci 50% 1.9401
Last Price 1.8550
Fibonacci 38.2% 1.7112
52-Week Low 0.9702

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar